Literature DB >> 36118400

Metastases of Renal Cell Carcinoma to the Contralateral Adrenal Gland Managed by Laparoscopic Adrenalectomy.

R B Nerli1,2, S M Patil1, Amey Pathade1, R A Patil1, N D Pingale1, P R Malur2.   

Abstract

Renal cell carcinoma (RCC) is the most lethal urological cancer. It is estimated that one thirds of the patients with localized cancer will develop distant metastasis after radical treatment. Adrenal metastasis of RCC are relatively rare and can be either synchronous or metachronous; ipsilateral, contralateral or bilateral; solitary or part of a massive metastatic spread. Contralateral adrenal metastasis are uncommon. It is well-known that some patients with isolated metastasis may benefit from surgical treatment. However, the optimal diagnosis and treatment of the contralateral adrenal metastasis from RCC has not yet been well defined. Since it was first described, laparoscopic adrenalectomy has become the gold standard for the surgical treatment of most adrenal conditions. The benefits of a minimally invasive approach to adrenal resection such as decreased hospital stay, shorter recovery time, and improved patient satisfaction are widely accepted. We report our experience with laparoscopic management of contralateral, metachronous adrenal metastases from RCC. Patients undergoing radical/partial nephrectomy for RCC were prospectively followed and evaluated regularly for general health status, local recurrence of tumor, and distant metastases. Patients identified to have had adrenal lesion/mass during the follow-up period were evaluated in detail both with imaging as well as endocrinal evaluation for assessment of functional status of these lesions. All these patients underwent laparoscopic adrenalectomy under general anesthesia. During the study period Jan 2006-Dec 2015, 8 patients (7 male and 1 female) with a mean age of 57.8 years underwent laparoscopic adrenalectomy. The mean operating time was 111.2 ± 32.5 min, blood loss was 45 ± 8.6 cm3 and postoperative stay was 37.5 ± 9.3 h. None of the patients had any major complications both early and delayed. The overall survival was 44.62 months. Metachronous, solitary, and contralateral adrenal metastasis from RCC is an extremely rare clinical complication that can occur very late after the radical/partial nephrectomy. Increased use of imaging modalities has led to more efficient and early detection of these lesions. Aggressive surgery remains the treatment of choice in these cases. Laparoscopic adrenalectomy remains a good, safe option with minimal morbidity and short hospital stay. © Indian Association of Surgical Oncology 2017.

Entities:  

Keywords:  Adrenal gland; Adrenalectomy; Laparoscopy; Metastases; Renal cell carcinoma; Surgical technique

Year:  2017        PMID: 36118400      PMCID: PMC9478078          DOI: 10.1007/s13193-017-0662-1

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  11 in total

Review 1.  Results of surgical treatment of kidney cancer with solitary metastasis to contralateral adrenal.

Authors:  J Plawner
Journal:  Urology       Date:  1991-03       Impact factor: 2.649

Review 2.  Metachronous renal cell carcinoma metastasis to the contralateral adrenal gland.

Authors:  O J Kessler; E Mukamel; R Weinstein; E Gayer; M Konichezky; C Servadio
Journal:  Urology       Date:  1998-04       Impact factor: 2.649

3.  Laparoscopic adrenalectomy for adrenal masses in children.

Authors:  Rajendra B Nerli; Mallikarjun N Reddy; Ajaykumar Guntaka; Shivagouda Patil; Murigendra Hiremath
Journal:  J Pediatr Urol       Date:  2010-05-21       Impact factor: 1.830

4.  Laparoscopic adrenalectomy for metachronous metastases after ipsilateral nephrectomy for renal-cell carcinoma.

Authors:  E Jason Abel; Jose A Karam; Alonso Carrasco; Surena F Matin
Journal:  J Endourol       Date:  2011-07-20       Impact factor: 2.942

5.  Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review.

Authors:  W K Lau; H Zincke; C M Lohse; J C Cheville; A L Weaver; M L Blute
Journal:  BJU Int       Date:  2003-06       Impact factor: 5.588

6.  Laparoscopic adrenalectomy for large pheochromocytoma.

Authors:  Ravish R Indupur; Rajendra B Nerli; Mallikarjun N Reddy; Suresh N Siddappa; Rohan Thakkar
Journal:  BJU Int       Date:  2007-09-03       Impact factor: 5.588

7.  Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

Authors:  Daniel Y C Heng; Wanling Xie; Meredith M Regan; Mark A Warren; Ali Reza Golshayan; Chakshu Sahi; Bernhard J Eigl; J Dean Ruether; Tina Cheng; Scott North; Peter Venner; Jennifer J Knox; Kim N Chi; Christian Kollmannsberger; David F McDermott; William K Oh; Michael B Atkins; Ronald M Bukowski; Brian I Rini; Toni K Choueiri
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

8.  Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.

Authors:  Alessandro Antonelli; Alberto Cozzoli; Claudio Simeone; Danilo Zani; Tiziano Zanotelli; Elena Portesi; Sergio Cosciani Cunico
Journal:  BJU Int       Date:  2006-03       Impact factor: 5.588

Review 9.  Contralateral adrenal metastasis in renal cell cancer.

Authors:  K P Dieckmann; A Wullbrand; G Krolzig
Journal:  Scand J Urol Nephrol       Date:  1996-04

10.  Management of renal cell carcinoma with solitary metastasis.

Authors:  Yuvaraja B Thyavihally; Umesh Mahantshetty; Ravichand S Chamarajanagar; Srinivas G Raibhattanavar; Hemant B Tongaonkar
Journal:  World J Surg Oncol       Date:  2005-07-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.